Fluctuating vision is the most frequently cited complaint, exceeding classic discomfort symptoms, and may divert patients toward refractive explanations before DED is recognized and treated.
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Gilead Sciences (NasdaqGS:GILD) plans to present late breaking data at CROI 2026 ...
A new AI-based method reconstructs spatial information about where immune cells were originally located in an organ, even after these cells have been removed from the tissue and analyzed individually.
Perioperative enfortumab vedotin plus pembrolizumab in KEYNOTE-B15/EV-304 met event-free and overall survival end points versus gemcitabine-cisplatin, with tolerability and post-cystectomy feasibility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results